logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10149852 B1

PDFFull Text
Date of Patent:
Dec. 11, 2018

Filed:

Sep. 16, 2016

Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

Applicant:

Wex Medical Limited, Wanchai, HK;

Inventors:

Helmut Heinrich Buschmann, Barcelona, ES;

Jose Miguel Vela Hernandez, Barcelona, ES;

Jose Manuel Baeyens, Granada, ES;

Susan Lu, Vancouver, CA;

Donald Wong, Vancouver, CA;

Walter Korz, Vancouver, CA;

Assignee:

WEX PHARMACEUTICALS INC., Vancouver, British Columbia, CA;

Attorney:

Morgan, Lewis & Bockius LLP

Primary Examiner:

Shobha Kantamneni

Int. Cl.
CPC ...
A61K 31/35 (2006.01); A61K 31/505 (2006.01); A61K 31/529 (2006.01); A61K 31/337 (2006.01); A61K 31/475 (2006.01); A61K 31/517 (2006.01); A61K 33/24 (2006.01); A61K 45/06 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01);
U.S. Cl.
CPC ...
A61K 31/529 (2013.01); A61K 31/337 (2013.01); A61K 31/475 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 33/24 (2013.01); A61K 45/06 (2013.01);
Abstract

The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the use are described.

Find Patent Forward Citations

Buschmann, Helmut. (2018). Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy (U.S. Patent No. 10149852). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10149852

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…